Literature DB >> 27376730

Noncoding RNAs: New Players in Cancers.

Xueman Chen1, Siting Fan1, Erwei Song2.   

Abstract

The world of noncoding RNAs (ncRNAs) has gained widespread attention in recent years due to their novel and crucial potency of biological regulation. Noncoding RNAs play essential regulatory roles in a broad range of developmental processes and diseases, notably human cancers. Regulatory ncRNAs represent multiple levels of structurally and functionally distinct RNAs, including the best-known microRNAs (miRNAs), the complicated long ncRNAs (lncRNAs), and the newly identified circular RNAs (circRNAs). However, the mechanisms by which they act remain elusive. In this chapter, we will review the current knowledge of the ncRNA field, discussing the genomic context, biological functions, and mechanisms of action of miRNAs, lncRNAs, and circRNAs. We also highlight the implications of the biogenesis and gene expression dysregulation of different ncRNA subtypes in the initiation and development of human malignancies.

Entities:  

Keywords:  Cancer; Circular RNA; Gene expression regulation; Long noncoding RNA; MicroRNA; Noncoding RNA

Mesh:

Substances:

Year:  2016        PMID: 27376730     DOI: 10.1007/978-981-10-1498-7_1

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  26 in total

1.  pri-miR-34b/c rs4938723 polymorphism is associated with hepatocellular carcinoma risk: a case-control study in a Chinese population.

Authors:  Chun-Jia Liu; Xue-Wei Ma; Xue-Jun Zhang; Shi-Qiang Shen
Journal:  Int J Mol Epidemiol Genet       Date:  2017-02-15

2.  LncRNA, a novel target biomolecule, is involved in the progression of colorectal cancer.

Authors:  Weihong Sun; Shaoshao Ren; Ran Li; Qingshan Zhang; Haiping Song
Journal:  Am J Cancer Res       Date:  2019-11-01       Impact factor: 6.166

Review 3.  Colorectal Cancer: From the Genetic Model to Posttranscriptional Regulation by Noncoding RNAs.

Authors:  María Antonia Lizarbe; Jorge Calle-Espinosa; Eva Fernández-Lizarbe; Sara Fernández-Lizarbe; Miguel Ángel Robles; Nieves Olmo; Javier Turnay
Journal:  Biomed Res Int       Date:  2017-05-10       Impact factor: 3.411

Review 4.  CircRNA-Associated CeRNAs Regulatory Axes in Retinoblastoma: A Systematic Scoping Review.

Authors:  Mohammad Reza Asadi; Marziyeh Sadat Moslehian; Hani Sabaie; Mirmohsen Sharifi-Bonab; Parvin Hakimi; Bashdar Mahmud Hussen; Mohammad Taheri; Azadeh Rakhshan; Maryam Rezazadeh
Journal:  Front Oncol       Date:  2022-07-05       Impact factor: 5.738

Review 5.  Mammary stem cells: angels or demons in mammary gland?

Authors:  Xueman Chen; Qiang Liu; Erwei Song
Journal:  Signal Transduct Target Ther       Date:  2017-01-13

Review 6.  Circular RNAs: Regulators of Cancer-Related Signaling Pathways and Potential Diagnostic Biomarkers for Human Cancers.

Authors:  Zuozhang Yang; Lin Xie; Lei Han; Xin Qu; Yihao Yang; Ya Zhang; Zewei He; Yu Wang; Jing Li
Journal:  Theranostics       Date:  2017-07-22       Impact factor: 11.556

7.  Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis.

Authors:  Yufeng Wang; Zhikui Liu; Bowen Yao; Qing Li; Liang Wang; Cong Wang; Changwei Dou; Meng Xu; Qingguang Liu; Kangsheng Tu
Journal:  Mol Cancer       Date:  2017-07-17       Impact factor: 27.401

8.  Novel circular RNA expression profile of uveal melanoma revealed by microarray.

Authors:  Xuan Yang; Yang Li; Yueming Liu; Xiaolin Xu; Yingzhi Wang; Yanni Yan; Wenjia Zhou; Jingyan Yang; Wenbin Wei
Journal:  Chin J Cancer Res       Date:  2018-12       Impact factor: 5.087

Review 9.  The Roles of circMTO1 in Cancer.

Authors:  Wei Liu; Yuanyuan Xiong; Renhua Wan; Renfeng Shan; Jianfeng Li; Wu Wen
Journal:  Front Cell Dev Biol       Date:  2021-06-30

10.  TUG1 promotes osteosarcoma tumorigenesis by upregulating EZH2 expression via miR-144-3p.

Authors:  Jiaqing Cao; Xinyou Han; Xin Qi; Xiangyun Jin; Xiaolin Li
Journal:  Int J Oncol       Date:  2017-08-30       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.